More recent work from these authors has shown that repeated exposure to acrolein potentiates meningeal vasodilatory responses to TRPA1 and TRPV1 activation [110] and leads to migraine-like cutaneous hypersensitivity and increased responses of the trigeminal afferent system to touch [111]. The gene discussed is TRPA1; the disease is migraine disorder.